期刊文献+

正常生理和1型糖尿病病理下慢性生长激素刺激对肝脏胰岛素信号的影响 被引量:1

The influence of chronic growth hormone stimulation on hepatic insulin signal under normal physiological and T1DM condition
下载PDF
导出
摘要 目的研究1型糖尿病(type 1 diabetes mellitus,T1DM)状态下长期生长激素(growth hormone,GH)治疗对肝脏胰岛素信号的影响及其可能机制。方法用慢性GH注射健康小鼠与链尿佐菌素(STZ)诱导的T1DM小鼠,Western blotting检测Akt和PTEN等。结果在健康Balb/c小鼠,GH慢性刺激可抑制肝内胰岛素信号通路分子Akt磷酸化(P<0.05),而该信号通途的负调控分子PTEN表达则显著增加(P<0.05);在T1DM C57BL/6小鼠,慢性GH刺激同样抑制肝内Akt磷酸化(P<0.05),而PTEN表达水平则无显著改变(P>0.05)。同时检测胰岛素信号的另一个负调节因子p85调节亚基,当经慢性GH刺激后,其表达水平在两种小鼠中均没有变化(P>0.05)。结论长期使用GH治疗可以抑制肝脏胰岛素信号,其机制涉及PTEN表达的升高,但其病理状态下的机制则不同。 Objective To research the influence and possible mechanism of chronic growth hormone (GH) on he- patic insulin signal under type 1 diabetes mellitus (T1DM) condition. Methods Chronic GH induced insulin resistance in mice with T1 DM which induced by Streptozoein (STZ). Then hepatic Akt phosphorylation and PTEN were detected by Western blotting. Results In healthy mice, chronic GH treatment inhibited hepatic p-Akt. PTEN expression was in- creased (P 〈 0.05 ). In T1DM mice, chronic GH caused similar inhibition of p-Akt ( P 〈 0.05 ), but PTEN expression did not change (P 〉 0.05). The p85 expression did not change in both health and T1 DM mice after chronic GH treat- ment (P 〉 0.05). Conclusion Long-term use of chronic GH treatment can inhibite hepatic insulin signaling and the mechanism involves the increasing PTEN expression, but the underlying mechanism is different in pathological status.
出处 《胃肠病学和肝病学杂志》 CAS 2016年第1期80-83,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 国家自然科学基金(81170743)
关键词 生长激素 胰岛素抵抗 PTEN PI3K通路 1型糖尿病 Growth hormone Insulin resistance PTEN PI3K Type 1 diabetes mellitus
  • 相关文献

参考文献9

  • 1Mo D, Hardin DS, Erfurth EM, et al. Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Con- trol and Complications Study (HypoCCS) [J]. Pituitary, 2014, 17 (5) : 477-485.
  • 2Kaspers S, Ranke MB, Han D, et al. hnplications of a data-driven ap- proach to treatment with growth hormone in children with growth hor- mone deficiency and Turner syndrome [ J]. Appl Health Econ Health Policy, 2013, 11(3) : 237-249.
  • 3Wiezel D, Assadi MH, Landau D, et al. Impaired renal growth hor-mone JAK/STAT5 signaling in chronic kidney disease [ J]. Nephrol Dial Transplant, 2014, 29(4): 791-799.
  • 4王飞,邱林.生长激素治疗儿童烧伤的研究进展[J].中华烧伤杂志,2013,29(1):18-21. 被引量:9
  • 5Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy [ J]. Cell Signal, 2002, 14 (5): 381-395.
  • 6钟秋安,仇小强,蒋俊俊,等.糖尿病与原发性肝癌关系队列研究的Meta分析[J].肿瘤防治研究,2005,12(13):755-757.
  • 7Stiles BL, Kuralwalla-Martinez C, Guo W, et al. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes [ J ]. Mol Cell Biol, 2006, 26 ( 7 ) : 2772-2781.
  • 8Wang L, Liu Y, Yan Lu S, et al. Deletion of Pten in pancreatic β- cells protects against deficient B-cell mass and function in mouse mod- els of type 2 diabetes [ J ]. Diabetes, 2010, 59 ( 12 ) : 3117-3126.
  • 9Bennett RA, Pegg AE. Alkylation of DNA in rat tissues following ad- ministration of streptozotocin [ J]. Cancer Res, 1981, 41 (7) : 2786-2790.

二级参考文献29

  • 1沈峻,孙晖,邰宁正,刘昌,孙炳伟.重组人生长激素在婴幼儿烧伤的临床应用[J].江苏大学学报(医学版),2004,14(30):214-215. 被引量:3
  • 2Reh CS, Geffner ME. Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review. Clin Pharmacol, 2010, 2 : 111-122.
  • 3Mauras N, Haymond MW. Are the metabolic effects of GH and IGF-1 separable? Growth Horm IGF Res, 2005, 15 (1) : 19- 27.
  • 4Jeschke MG, Mlcak RP, Finnerty CC, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care, 2007, 11(4) : R90.
  • 5Jeschke MG, Barrow RE, Mlcak RP, et al. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg, 2005, 241(5): 759-768.
  • 6Jeschke MG,Mlcak RP, Finnerty CC, et al. Gender differences in pediatric burn patients: does it make a difference? Ann Surg, 2008, 248(1) : 126-136.
  • 7Gauqlitz GG, Herndon DN, Kulp GA, et al. Abnormal insulin sensitivity persists up to three years in pediatric patients postburn. J Clin Endocrinol Metab,2009,94(5) :1656-1664.
  • 8Jeschke MG, Gauqlitz GG, Kulp GA, et al. Long-term persis- tance of the pathophysiologic response to severe burn injury. PLoS One, 2011,6(7) : e21245.
  • 9Przkora R, Barrow RE, Jeschke MG, et al. Body composition changes with time in pediatric burn patients. J Trauma, 2006, 60 (5) : 968-971.
  • 10Rutan RL, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg, 1990, 125(3) :392-395.

共引文献8

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部